The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 25th 2025
Evolocumab is now indicated for adults at increased risk for major adverse cardiovascular events (MACE).